Whether general or specialized, hospitals in emerging markets continually capture and use clinical data to provide routine and acute care, screening and diagnostic tests, and a wide array of medical and surgical treatments. This clinical data is essential to meeting a hospital’s core mission of delivering safe and effective patient care. When digitized, de-identified, and aggregated with data from other hospitals in currently underserved parts of the world, this same data can provide essential insights for creating a more comprehensive understanding of patient journeys.
In short, hospitals in emerging markets represent critical – and currently underutilized – resources in pushing the boundaries of medical research, drug discovery, and attaining global health equity.
Syndesis Health is forging a global network of hospitals in emerging markets to deliver on this vision. The Syndesis Health Network provides secure access to global, truly inclusive RWE to a range of data consumers, including pharmaceutical companies, CROs, digital health innovators, and medical researchers in general.
Initially, we are focused on working with institutions that we consider “centers of excellence” in their respective geographies and specialties. The institutions have largely adopted Electronic Health Records (EHR) in their practice and have data of sufficient depth and longitudinality to support RWE use cases, such as drug discovery, clinical trial recruitment, and post-market surveillance of drug safety and efficacy.
However, we are not limiting the network to centers of excellence. Syndesis Health also expects to collaborate with hospitals that are still managing the transition to digital records. We can help these hospitals begin to transform the collection and management of healthcare data so that they can become participants in medical research at scale.